Company research / GEVO

Gevo, Inc. (GEVO)

CIK 0001392380 · Nasdaq · Industrial Organic Chemicals

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Gevo, Inc. reported revenue of $160.58M. Revenue grew 849.3% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $177.51M.

Key ratios (year ended 2025-12-31)

-12.6%
Operating margin
-21.1%
Net margin
-7.3%
Return on year-end equity
849.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-04

Headquarters locality: Douglas County · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$177.51M$160.58M$16.91M$17.20M$1.18M$533.0K$5.46M$24.45M$32.86M$27.31M$26.54M
Cost of Revenuen/an/an/an/an/an/a$15.00M$36.73M$41.57M$38.16M$37.02M
Gross Profitn/an/an/an/an/a-$11.45M-$9.47M-$12.25M-$8.71M-$10.63M-$9.80M
R&D Expense$4.50M$4.55M$5.58M$6.64M$7.43M$6.78M$3.51M$3.87M$5.37M$5.18M$5.22M
Operating Income-$182.47M-$20.21M-$90.82M-$81.83M-$102.69M-$60.27M-$26.96M-$26.36M-$22.20M-$23.28M-$23.98M
Depreciation & Amortization$26.13M$25.32M$18.30M$19.01M$7.89M$5.13M$5.90M$6.66M$6.52M$6.64M$6.75M
EBITDA-$156.34M$5.11M-$72.53M-$62.83M-$94.80M-$55.14M-$21.06M-$19.70M-$15.68M-$16.64M-$17.24M
Net Income-$212.89M-$33.84M-$78.64M-$66.22M-$98.01M-$59.20M-$40.19M-$28.66M-$27.98M-$24.63M-$37.23M
EPS (Diluted)n/a-$0.14-$0.34-$0.28-$0.44-$0.30n/an/an/an/an/a
Total Assets$490.71M$718.93M$583.94M$650.32M$700.75M$645.38M$152.10M$93.36M$107.03M$88.85M$112.32M
Total Liabilities$209.76M$247.76M$94.45M$92.93M$95.27M$98.13M$5.72M$20.86M$18.25M$25.32M$43.06M
Long-Term Debt$167.24M$164.75M$67.13M$68.12M$67.54M$66.96M$1.25M$749.0Kn/an/a$35.68M
Shareholders' Equity$273.16M$466.34M$489.49M$557.39M$605.48M$547.25M$146.38M$72.50M$88.79M$63.53M$69.26M
Cash & Equivalents$58.15M$81.16M$189.39M$298.35M$237.12M$40.83M$78.34M$16.30M$33.73M$11.55M$27.89M
Operating Cash Flow-$16.25M-$13.40M-$57.38M-$53.72M-$44.31M-$48.27M-$19.34M-$20.84M-$15.85M-$20.63M-$20.52M
Capital Expenditures$40.41M$30.11M$51.09M$54.45M$84.08M$56.77M$6.22M$6.50M$2.23M$1.91M$5.94M
Free Cash Flow-$56.65M-$43.51M-$108.47M-$108.17M-$128.39M-$105.04M-$25.55M-$27.34M-$18.08M-$22.53M-$26.45M
Share Repurchasesn/an/a$4.71Mn/an/an/an/an/an/an/an/a
Shares Outstanding247.24M242.46M239.18M240.50M237.17M201.99M128.14M14.08M8.64M1.09M7.07M
Weighted Average Diluted Sharesn/a234.01M231.67M238.69M221.54M195.79Mn/an/an/an/an/a
EPS (Basic)n/a-$0.14-$0.34-$0.28-$0.44-$0.30n/an/an/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView